Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports
Here, we discuss two cases with ITP secondary Epstein barr virus infection.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Immune thrombocytopenia (ITP) is a reason of thrombocytopenia that is characterized by isolated thrombocytopenia in childhood.
📊
Key Findings & Data:Epstein barr virus infection (EBV) is a mildly and uncomplicated ailment that might be a trigger factor for ITP.
💡
Conclusion & Impact:Here, we discuss two cases with ITP secondary Epstein barr virus infection.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Immun thrombocytopenia · Epstein-Barr virus · children
Abstract
Immune thrombocytopenia (ITP) is a reason of thrombocytopenia that is characterized by isolated thrombocytopenia in childhood. Epstein barr virus infection (EBV) is a mildly and uncomplicated ailment that might be a trigger factor for ITP. Here, we discuss two cases with ITP secondary Epstein barr virus infection.
Özet
İmmün trombositopeni (ITP), çocukluk çağında izole trombositopeni ile karakterize bir trombositopeni nedenidir. Epstein barr virüs enfeksiyonu (EBV) ITP için tetikleyici bir faktör olabilecek hafif ve komplikasyonsuz bir hastalıktır. Burada, Epstein barr virüs enfeksiyonuna ikincil ITP gelişen iki olgu tartışılmıştır.
Gökçe, Ş., Tosyalı, M., Şafaklı, A., Yıldırım, R., Ahmadov, N. B. K., Tunçalp, G., Bostancı, N., Mammadova, A., Çelebi, E. G., Şahin, N. N., Türksönmez, Ç., Erol, A., Köse, H. O., Koç, F. U. (2024). Primary Active Epstein-Barr Virus Infection Coexisting with Immune Thrombocytopenia in Children-A Rare Trigger Factor of Immun Thrombocytopenia: Two Case Reports. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Volume: 11 Issue: 1. https://doi.org/10.34087/cbusbed.1433575
Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113:2386–2393.
Correia S, Bridges R, Wegner F, et al. Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases. J Virol 2018; 92: e01132-18.
Pipp ML, Means ND, Sixbey JW, Morris KL, Gue CL, Baddour LM. Acute Epstein- Barr virus infection complicated by severe thrombocytopenia. Clin Infect Dis 1997; 25:1237–9.
Zeller B, Rajantie J, Hedlund-Treutiger I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 2005; 94:178-84.
Chiang MR, Wei CC, Muo CS, Fu LS, Li TC, Kao CH. Association of primary immune thrombocytopenia and common allergic diseases among children. Pediatr Res 2015; 77:597-601.
Elalfy MS, Nugent D. Viruses, anti-viral therapy, and viral vaccines in children with immune thrombocytopenia. Semin Hematol 2016; 53:70-72.
Nielsen TR, Rostgaard K, Nielsen NM, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007; 64:72-75.
Norris PAA, Kaur G, Lazarus AH. New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases. Curr Opin Hematol 2020; 27:392-398